Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Fluarix approved in U.S.

Sep. 2, 2005

Pharmexa licenses Biogen Idec's Provax adjuvant

Sep. 2, 2005

Belatacept found as effective and better tolerated than ciclosporin in renal transplant recipients

Sep. 1, 2005

MedImmune licenses rights from GSK to BSYX-A110

Sep. 1, 2005

Acambis on track to begin phase III trials of ChimeriVax-JE by year-end

Aug. 31, 2005

Acambis and VIB team up on flu vaccine development

Aug. 17, 2005

Halofuginone modulates T-cell functional activity

Aug. 16, 2005

European authorities approve phase III studies of Japanese encephalitis vaccine

Aug. 11, 2005

Novel immunomodulatory agents disclosed in recent patents

Aug. 9, 2005

KBMA vaccines: novel strategy for safe protective immunity

Aug. 9, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...